ARTICLE | Clinical News
CollaRx gentamicin topical: Completed Phase III enrollment
July 11, 2016 7:00 AM UTC
Innocoll completed enrollment of about 500 patients in the double-blind, placebo-controlled, U.S. Phase III COACT-1 trial of Cogenzia given for 28 days. ...